| Ytd | -63.81% | |
| 1y | -85.68% |
| Open | 4.29 | Prev Close | 4.29 | Low | 4.29 | High | 4.30 | Mkt Cap | 2.33M |
| Vol | 4.00K | Avg Vol | 87.48K | EPS | -7.64 | P/E | -0.56 | Forward P/E | -0.46 |
| Beta | -1.32 | Short Ratio | 0.06 | Inst. Own | 17.72% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 7.13 | 200-d Avg | 11.67 | 1yr Est | 28.00 |
Gainers Ernexa Therapeutics (NASDAQ:ERNA) stock increased by 88.3% to $11.41 during Wednesday's
Newly Issued Patent Expands Company's Neural Sensing Technology Platform into Large Urology Market A
THE WOODLANDS, TX, July 13, 2026 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) ("Autono
Autonomix Medical Inc (NASDAQ:AMIX) has been granted a new patent strengthening its neural sensing i
Autonomix Medical Inc (NASDAQ:AMIX) has been granted a new patent strengthening its neural sensing i
The newly issued patent expands and reinforces Autonomix's intellectual property estate related
IP portfolio reflects Autonomix's neural sensing leadership in multi-billion-dollar denervation mark
Platform Expected to Target Expansion into Multi-Billion-Dollar Cardiovascular Market with Potential
THE WOODLANDS, TX, June 18, 2026 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) ("Autono
Access the segment here THE WOODLANDS, TX, June 10, 2026 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc
Dr. Toufic Kachaamy Discusses Visceral Cancer Pain Treatment Differentiation, Pancreatic Cancer Feas
Shares of 8x8 Inc (NASDAQ: EGHT) jumped 13.3% in pre-market trading after reporting better-than-expe
Technology unlocks minimally invasive transvascular access to nerve targets and tissues through and
THE WOODLANDS, TX, May 18, 2026 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) ("Autonom
THE WOODLANDS, TX, April 29, 2026 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Auton
Autonomix Medical (NASDAQ: AMIX - Get Free Report) and Pacific Biosciences of California (NASDAQ: PA
THE WOODLANDS, TX, April 22, 2026 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Auton